Ohcanbohtosat - Isaacs, John D.
- Čájehuvvo 1 - 20 / 91
- Sirdás čuovvovaš siidui
-
1
Antibody engineering to develop new antirheumatic therapies Dahkki Isaacs, John D
Almmustuhtton 2009Teaksta -
2
-
3
-
4
-
5
-
6
Basic Mechanisms of JAK Inhibition Dahkki Lin, Chung MA, Cooles, Faye AH, Isaacs, John D.
Almmustuhtton 2020Teaksta -
7
-
8
-
9
Emerging immunotherapies for rheumatoid arthritis Dahkki Reynolds, Gary, Cooles, Faye AH, Isaacs, John D, Hilkens, Catharien MU
Almmustuhtton 2014Teaksta -
10
-
11
-
12
-
13
-
14
Predicting persistent inflammatory arthritis amongst early arthritis clinic patients in the UK: is musculoskeletal ultrasound required? Dahkki Pratt, Arthur G, Lorenzi, Alice R, Wilson, Gill, Platt, Philip N, Isaacs, John D
Almmustuhtton 2013Teaksta -
15
Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data Dahkki Pratt, Arthur G., Lendrem, Dennis, Hargreaves, Ben, Aslam, Osman, Galloway, James B., Isaacs, John D.
Almmustuhtton 2016Teaksta -
16
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents Dahkki Strand, Vibeke, Gonçalves, Joao, Hickling, Timothy P., Jones, Heather E., Marshall, Lisa, Isaacs, John D.
Almmustuhtton 2019Teaksta -
17
Correction to: Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents Dahkki Strand, Vibeke, Gonçalves, Joao, Hickling, Timothy P., Jones, Heather E., Marshall, Lisa, Isaacs, John D.
Almmustuhtton 2020Teaksta -
18
-
19
Lack of association between clinical and ultrasound measures of disease activity in rheumatoid arthritis remission Dahkki Baker, Kenneth F., Thompson, Ben, Lendrem, Dennis W., Scadeng, Adam, Pratt, Arthur G., Isaacs, John D.
Almmustuhtton 2020Teaksta -
20